| Compounding for animal patients: contemporary issues. | |
| | |
MedLine Citation:
|
PMID: 15191248 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To provide background information relating to the growth observed in veterinary compounding, discuss positive contributions made to animal health via compounding, present compounding practices that are in the best interest of patient care, present documents available to pharmacists to use for guidance when practicing veterinary pharmacy, and emphasize the need for education among stakeholders on the subject of veterinary compounding. DATA SOURCES: The Animal Medicinal Drug Use Clarification Act of 1994, compliance policy guide section 608.400, the American Veterinary Medical Association Position Statement on Compounding and Extralabel Drug Use Algorithm; supporting data from veterinary and pharmacy literature documenting the practice of veterinary compounding are referenced (SilverPlatter Medline 1966-2002 and International Pharmaceutical Abstracts; 1970 through December 2002; no restrictions; search terms, veterinary AND compounding). STUDY SELECTION: By the author. DATA EXTRACTION: By the author. DATA SYNTHESIS: Requests for compounding of products for veterinary uses are common in community pharmacy, and these preparations fill many clinical, dosing, and drug-administration needs in the care of companion animals. However, like other elements of pharmacy compounding, preparation of veterinary products falls into a legally gray area that is the subject of current scrutiny by the U.S. Food and Drug Administration (FDA). Pharmacists involved in this practice should keep the best interests of the animal in mind; recognize limitations about safety, effectiveness, and stability of compounded formulations; and avoid preparing products similar in ingredients and purpose as commercially available, FDA-approved products. Situations in which compounding becomes manufacturing invites enforcement action by FDA. The dispensing of compounded products should be based on a valid veterinarian-client-patient relationship and comply with federal acts, FDA's compounding compliance policy guide, and other such resources. CONCLUSION: All pharmacists and pharmacies engaged in any type of veterinary pharmacy practice must be aware of the contemporary issues facing their profession. Best patient care practices, education, and open communication among stakeholders will play a critical role in the practice and future regulation of veterinary compounding. |
| | |
Authors:
|
Elaine Lust |
Related Documents
:
|
22476668 - Building co-management as a process: problem solving through partnerships in aboriginal... 18403428 - Charles e. rosenberg and the multifaceted promise of medical history. 21073248 - Johannes ludwig janson, professor of veterinary medicine in tokyo in 1880-1902 - contri... 22440868 - The role of adjuvant radiation therapy in the management of high-grade gliomas. 18045978 - Cpd for gps using the thor-gp website. 12170158 - Acoustic neuroma management: an evidence-based medicine approach. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of the American Pharmacists Association : JAPhA Volume: 44 ISSN: 1544-3191 ISO Abbreviation: J Am Pharm Assoc (2003) Publication Date: 2004 May-Jun |
Date Detail:
|
Created Date: 2004-06-11 Completed Date: 2004-06-29 Revised Date: 2007-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 101176252 Medline TA: J Am Pharm Assoc (2003) Country: United States |
Other Details:
|
Languages: eng Pagination: 375-84; quiz 384-6 Citation Subset: IM |
Affiliation:
|
Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA. elainel@creighton.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Algorithms Animals Drug Compounding / veterinary* Legislation, Pharmacy United States Veterinary Drugs / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Veterinary Drugs |
| Comments/Corrections | |
Comment In:
|
J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):532
[PMID:
15496038
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Counseling Spanish-speaking patients: Atlanta pharmacists' cultural sensitivity, use of language-ass...
Next Document: Using buzz marketing to promote ideas, services, and products.